C4 Therapeutics Inc. Gains 98.31%

Tue, Dec 12, 2023 at 07:15 PM

C4 Therapeutics Inc. (CCCC:NASDAQ) jumped higher at $2.34, a gain of 98.3%. On Tue, Dec 12, 2023, CCCC:NASDAQ touched a New 2-Week High of $2.34. The stock got featured on our News Catalysts scanner on Tue, Dec 12, 2023 at 05:55 PM in the 'BIOTECH' category. From Tue, Nov 28, 2023, the stock recorded 40.00% Up Days and 36.36% Green Days

About C4 Therapeutics Inc. (CCCC:NASDAQ)

C4 Therapeutics Inc is a bio-pharmaceutical company.

Top 10 Gainers:

SRAX, Inc. (SRAX:NASDAQ), 150%
C4 Therapeutics Inc. (CCCC:NASDAQ), 98.31%
Vinco Ventures Inc. (BBIG:NASDAQ), 66.67%
Kubient Inc. (KBNT:NASDAQ), 62.5%
Aditxt Inc. (ADTX:NASDAQ), 60.26%
Icosavax Inc. (ICVX:NASDAQ), 49.48%
Chanson International Holding (CHSN:NASDAQ), 36.56%
Evofem Biosciences, Inc. (EVFM:NASDAQ), 35.71%
Hanryu Holdings, Inc. (HRYU:NASDAQ), 35.05%
Altamira Therapeutics Ltd. (CYTO:NASDAQ), 34%